Streetbeat News

MLTX

MoonLake Immunotherapeutics

https://www.moonlaketx.com

Industry

Biotechnology

MoonLake Immunotherapeutics, a clinical-stage biopharmaceutical company, engages in developing therapies. It is developing Sonelokimab, a novel investigational Nanobody therapy for the treatment of inflammation. The company is involved in conducting Phase II trials for hidradenitis suppurativa, psoriatic arthritis, ankylosing spondylitis, or radiographic axial spondyloarthritis. MoonLake Immunotherapeutics was founded in 2021 and is headquartered in Zug, Switzerland.

Open

51.98

Mkt cap

3.1B

Volume

401K

High

51.98

P/E Ratio

-38.45

52-wk high

64.98

Low

48.30

Div yield

N/A

52-wk low

37.55

Wedbush analyst Andreas Argyrides has maintained an Outperform rating on MoonLake (NASDAQ:MLTX) and raised the price target from $61 to $86.

Portfolio Pulse from Benzinga Newsdesk

July 31, 2023 | 4:22 pm

Analysts have provided bullish ratings for MoonLake (NASDAQ:MLTX) within the last quarter, with 8 bullish, 1 somewhat bullish, and 2 indifferent ratings. The average 12-month price target for MoonLake has increased by 40.51% from the previous average price target of $35.00 to $49.18, with a high of $75.00 and a low of $28.00.

Portfolio Pulse from Benzinga Insights

July 26, 2023 | 6:01 pm

HC Wainwright & Co. analyst Raghuram Selvaraju has reiterated a 'Buy' rating on MoonLake (NASDAQ:MLTX) and maintained a $75 price target.

Portfolio Pulse from richadhand@benzinga.com

July 26, 2023 | 10:24 am

Moonlake Immunotherapeutics has completed the randomization of the target 200 patients in its global Phase 2 ARGO trial evaluating Nanobody Sonelokimab in active psoriatic arthritis, several weeks ahead of schedule.

Portfolio Pulse from Benzinga Newsdesk

July 25, 2023 | 12:04 pm

The article lists potential short squeeze stocks to watch, including Baosheng Media Group Holdings, Toro Corp, Intuitive Machines, MoonLake Immunotherapeutics, Getty Images Holdings, AirSculpt Technologies, Ocean Biomedical, Joann Inc, Beam Global, and Minerva Neurosciences. These stocks have high short interest and steep borrowing costs, which could lead to a short squeeze. The stocks have been ranked based on data from the Fintel short squeeze leaderboard.

Portfolio Pulse from Chris Katje

July 18, 2023 | 4:04 pm

HC Wainwright has doubled the price target for MoonLake Immunotherapeutics (NASDAQ:MLTX) from $37 to $75 with a Buy rating, following positive results from its Phase 2 MIRA trial. The trial evaluated the Nanobody sonelokimab in patients with moderate-to-severe hidradenitis suppurativa (HS). The analyst raised the probability of approval for sonelokimab in HS and PsA to 70% and reduced the discount rate to 11% from 13%. MoonLake is also reportedly considering a potential sale.

Portfolio Pulse from Vandana Singh

July 17, 2023 | 6:39 pm

MoonLake Immunotherapeutics is reportedly exploring a sale, which has led to a rise in its share prices. Additionally, HC Wainwright & Co has increased its price target for the company from $37 to $75.

Portfolio Pulse from Benzinga Newsdesk

July 17, 2023 | 4:23 pm

Several companies have made significant announcements. Advanced Micro-Fabrication Equipment Inc and Naura Technology Group Co expect a doubling in profits due to the U.S. tech embargo. BlackRock Inc plans to expand its Voting Choice program to its largest ETF. Alibaba Group Holding Limited's stock is trading lower as China's Q2 GDP missed estimates. Ford Motor Co announced price cuts for its F-150 Lightning truck. Virgin Galactic Holdings Inc announced the crew of its seventh spaceflight. Rocket Lab USA Inc is preparing to launch a mix of satellites for NASA and commercial satellite constellation operators. Acumen Pharmaceuticals Inc's experimental Alzheimer's drug passed early safety tests. Sony Group Corp and Microsoft Corporation have reportedly reached a 10-year agreement to keep 'Call of Duty' games on PlayStation consoles. Proximus SA is acquiring a 58% stake in Route Mobile. Entain PLC plans to acquire Angstrom Sports. Hennes & Mauritz AB is launching its stores in Brazil. American Airlines Group Inc and JetBlue Airways Corp have initiated the process of dissolving the Northeast Alliance. United Airlines Holdings Inc and its pilots have reached a labor agreement with a substantial pay raise. MoonLake Immunotherapeutics is reportedly looking for a potential sale. Toshiba Corp plans to establish a supply chain for offshore wind power equipment in Japan with General Electric Company.

Portfolio Pulse from Vandana Singh

July 17, 2023 | 2:13 pm

MoonLake Immunotherapeutics (NASDAQ:MLTX) is reportedly seeking a potential sale and has engaged an investment bank for the process. The company, which focuses on antibody-derived treatments for inflammatory skin conditions, is in preliminary talks with interested pharmaceutical companies. MoonLake recently raised $400 million through a stock sale to fund the development of sonelokimab. Since its public debut in 2022, MoonLake's stock price has increased fivefold.

Portfolio Pulse from Vandana Singh

July 17, 2023 | 12:38 pm

HC Wainwright & Co. analyst Raghuram Selvaraju maintains a Buy rating on MoonLake (NASDAQ:MLTX) and raises the price target from $37 to $75.

Portfolio Pulse from richadhand@benzinga.com

July 17, 2023 | 10:18 am

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.